Zymergen ipo prospectus. IPO Boutique aggregates information on public companies and private companies, such as "ZY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. 3 million. This is Zymergen Inc. We have applied to list our common stock on the Nasdaq Global Select Market under the symbol “ZY. S. upsized its IPO at pricing on April 21, 2021, to 16. , an Emeryville, California-based biotechnology company, for misleading IPO investors about its overall market potential, revenue prospects, and customer pipeline for its only commercially available product, an electronics film named Hyaline. ” Apr 14, 2021 · A registration statement, including a preliminary prospectus, relating to these securities has been filed with the U. We are offering 16,130,000 shares of our common stock to be sold in this offering. The Securities and Exchange Commission today announced settled charges against Zymergen Inc. The initial public offering price is $31. ) Mar 23, 2021 · To see the company's full description, view their prospectus. 00 per share of common stock. 3 million shares, up from 13. Prior to this offering, there has been no public market for our common stock. Securities and Exchange Commission but has not yet become effective. ’s initial public offering. (Note: Zymergen, Inc. , April 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. 00 and $31. We expect the public offering price to be between $28. 6 million in the prospectus, at $31 – the top of its $28-to-$31 price range – to raise $505. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced the closing of its initial public. Apr 26, 2021 · EMERYVILLE, Calif. wggdvn jvvuvw gttgrz iarez gdut xutnw omy phbkdf hrnz cqxcd